The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Knowledge Center

Patent

Method for the production of fluoromethyl esters of androstane-17_-carboxylic acids

Jan 01, 2013 WO 2012160338

Patent

Application of high dose compounds via inhalation for treatment of pulmonary diseases

Jan 01, 2013 WO 2013104892

Article

New Technologies in Particle Design. Interview: Colin Minchom, VP, Particle Design Business Unit

Oct 01, 2012 Drug Development and Delivery, October 2012

Article

Seeking Solutions in Solid-State Chemistry

Oct 01, 2012 Pharmaceutical Technology, October 2012

Article

Supplier Qualification. A comparison of comprehensive third-party excipient GMP audit programs

Oct 01, 2012 Pharmaceutical Technology, October 2012

Article

Sphere of Influence

May 01, 2012 PMPS, May 2012

Article

Sphere of Influence

May 01, 2012 PMPS, May 2012

Article

A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea

Jan 01, 2012 Separation and Purification Technology (2012), 86, 79-87

Article

Carcinogenic pollutants in drug manufacturing

Jan 01, 2012 Magyar Kemikusok Lapja (2012), 67(2), 34-37

Browser not supported

Knowledge Center

Scientific Article Type

Authors

Publish Date

Method for administering high-dose inhalants

Production of near monodisperse particles using milling and membrane separation

Process for preparing tiotropium bromide from scopine oxalate

Method for the production of fluoromethyl esters of androstane-17_-carboxylic acids

Application of high dose compounds via inhalation for treatment of pulmonary diseases

New Technologies in Particle Design. Interview: Colin Minchom, VP, Particle Design Business Unit

Seeking Solutions in Solid-State Chemistry

Supplier Qualification. A comparison of comprehensive third-party excipient GMP audit programs

Sphere of Influence

Sphere of Influence

A hybrid approach to reach stringent low genotoxic impurity contents in active pharmaceutical ingredients: Combining molecularly imprinted polymers and organic solvent nanofiltration for removal of 1,3-diisopropylurea

Carcinogenic pollutants in drug manufacturing